{"transactions":[{"id":835823,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":59461,"kind":"person","name":"BUNKA CHRISTOPHER","position":1,"cik":"0001103780","reported_name":"BUNKA CHRISTOPHER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"common shares","published_at":"2026-03-18T15:37:13.000Z","date":"2026-03-17","kind":"gift","planned":false,"acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 100,000 shares were gifted back to Lexaria Bioscience Corp. and returned to treasury."}],"balance_after":273543,"source":{"system":"sec-edgar","filing":"0001103780-26-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1103780/000110378026000001/primary_doc.xml","form_type":"4"}},{"id":1079374,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":59461,"kind":"person","name":"BUNKA CHRISTOPHER","position":1,"cik":"0001103780","reported_name":"BUNKA CHRISTOPHER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"common shares","published_at":"2025-07-30T21:12:54.000Z","date":"2025-07-30","kind":"purchase","planned":false,"acquired":true,"shares":11900,"price":0.9131,"value":10865.89,"ownership":{"direct":false,"nature":"Private Holding Company"},"balance_after":281912,"source":{"system":"sec-edgar","filing":"0001348362-25-000016","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1103780/000134836225000016/primary_doc.xml","form_type":"4"}},{"id":1079373,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":59461,"kind":"person","name":"BUNKA CHRISTOPHER","position":1,"cik":"0001103780","reported_name":"BUNKA CHRISTOPHER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"common shares","published_at":"2025-07-30T21:12:54.000Z","date":"2025-07-29","kind":"purchase","planned":false,"acquired":true,"shares":15600,"price":0.9215,"value":14375.4,"ownership":{"direct":false,"nature":"Private Holding Company"},"balance_after":270012,"source":{"system":"sec-edgar","filing":"0001348362-25-000016","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1103780/000134836225000016/primary_doc.xml","form_type":"4"}},{"id":1079083,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":77080,"kind":"person","name":"McKechnie William Edward","position":1,"cik":"0001658613","reported_name":"McKechnie William Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"common shares","published_at":"2025-07-30T12:37:08.000Z","date":"2025-07-29","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":0.9063,"value":4531.5,"ownership":{"direct":true},"balance_after":18191,"source":{"system":"sec-edgar","filing":"0001348362-25-000015","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658613/000134836225000015/primary_doc.xml","form_type":"4"}},{"id":1079079,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":77079,"kind":"person","name":"DOCHERTY JOHN MARTIN","position":1,"cik":"0001638727","reported_name":"DOCHERTY JOHN MARTIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CSO"}}],"security":"common shares","published_at":"2025-07-30T11:34:10.000Z","date":"2025-07-29","kind":"purchase","planned":false,"acquired":true,"shares":5376,"price":0.928,"value":4988.928,"ownership":{"direct":true},"balance_after":5376,"source":{"system":"sec-edgar","filing":"0001348362-25-000014","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1638727/000134836225000014/primary_doc.xml","form_type":"4"}},{"id":1079229,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":77081,"kind":"person","name":"Carle Vanessa","position":1,"cik":"0001855763","reported_name":"Carle Vanessa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary"}}],"security":"common shares","published_at":"2025-07-30T11:23:09.000Z","date":"2025-07-29","kind":"purchase","planned":false,"acquired":true,"shares":750,"price":0.91,"value":682.5,"ownership":{"direct":true},"balance_after":750,"source":{"system":"sec-edgar","filing":"0001348362-25-000013","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855763/000134836225000013/primary_doc.xml","form_type":"4"}},{"id":1079036,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":77077,"kind":"person","name":"CHRISTOPHER RICHARD","position":1,"cik":"0001271244","reported_name":"CHRISTOPHER RICHARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"common shares","published_at":"2025-07-30T11:14:34.000Z","date":"2025-07-29","kind":"purchase","planned":false,"acquired":true,"shares":15000,"price":0.9094,"value":13641.0,"ownership":{"direct":true},"balance_after":65000,"source":{"system":"sec-edgar","filing":"0001348362-25-000012","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1271244/000134836225000012/primary_doc.xml","form_type":"4"}},{"id":1146118,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":59461,"kind":"person","name":"BUNKA CHRISTOPHER","position":1,"cik":"0001103780","reported_name":"BUNKA CHRISTOPHER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2025-05-16T21:39:39.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":184834,"derivative":{"exercise_price":1.04,"exercise_date":"2025-05-15","expiration_date":"2030-05-15","underlying":"Common Shares","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001348362-25-000010","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1103780/000134836225000010/primary_doc.xml","form_type":"4"}},{"id":1145107,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":77077,"kind":"person","name":"CHRISTOPHER RICHARD","position":1,"cik":"0001271244","reported_name":"CHRISTOPHER RICHARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2025-05-16T17:47:41.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":350000,"derivative":{"exercise_price":1.04,"exercise_date":"2025-05-15","expiration_date":"2030-05-15","underlying":"Common Shares","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001348362-25-000011","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1271244/000134836225000011/primary_doc.xml","form_type":"4"}},{"id":1145614,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":77081,"kind":"person","name":"Carle Vanessa","position":1,"cik":"0001855763","reported_name":"Carle Vanessa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary"}}],"security":"Stock Options","published_at":"2025-05-16T17:27:43.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":75000,"derivative":{"exercise_price":1.04,"exercise_date":"2025-05-15","expiration_date":"2030-05-15","underlying":"Common Shares","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001348362-25-000009","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1855763/000134836225000009/primary_doc.xml","form_type":"4"}},{"id":1145355,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":77079,"kind":"person","name":"DOCHERTY JOHN MARTIN","position":1,"cik":"0001638727","reported_name":"DOCHERTY JOHN MARTIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Options","published_at":"2025-05-16T17:19:02.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":310834,"derivative":{"exercise_price":1.04,"exercise_date":"2025-05-15","expiration_date":"2030-05-15","underlying":"Common Shares","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001348362-25-000008","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1638727/000134836225000008/primary_doc.xml","form_type":"4"}},{"id":1145796,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":79693,"kind":"person","name":"Shankman Michael Elliot","position":1,"cik":"0002035175","reported_name":"Shankman Michael Elliot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options","published_at":"2025-05-16T16:51:22.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":100000,"derivative":{"exercise_price":1.04,"exercise_date":"2025-05-15","expiration_date":"2030-05-15","underlying":"Common Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001348362-25-000007","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2035175/000134836225000007/primary_doc.xml","form_type":"4"}},{"id":1145163,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":79673,"kind":"person","name":"Bhullar Baljinder","position":1,"cik":"0001401225","reported_name":"Bhullar Baljinder","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2025-05-16T16:44:04.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":11000,"derivative":{"exercise_price":1.04,"exercise_date":"2025-05-15","expiration_date":"2030-05-15","underlying":"Common Shares","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001348362-25-000006","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401225/000134836225000006/primary_doc.xml","form_type":"4"}},{"id":1145013,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":79670,"kind":"person","name":"Baxter Nicholas W","position":1,"cik":"0001312326","reported_name":"Baxter Nicholas W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2025-05-16T16:40:21.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":63000,"derivative":{"exercise_price":1.04,"exercise_date":"2025-05-15","expiration_date":"2030-05-15","underlying":"Common Shares","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001348362-25-000005","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1312326/000134836225000005/primary_doc.xml","form_type":"4"}},{"id":1145085,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":79671,"kind":"person","name":"REESE ALBERT L JR","position":1,"cik":"0001244736","reported_name":"REESE ALBERT L JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2025-05-16T16:30:40.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":43000,"derivative":{"exercise_price":1.04,"exercise_date":"2025-05-15","expiration_date":"2030-05-15","underlying":"Common Shares","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001348362-25-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1244736/000134836225000004/primary_doc.xml","form_type":"4"}},{"id":1145362,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":77080,"kind":"person","name":"McKechnie William Edward","position":1,"cik":"0001658613","reported_name":"McKechnie William Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2025-05-16T16:18:27.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":63000,"derivative":{"exercise_price":1.04,"exercise_date":"2025-05-15","expiration_date":"2030-05-15","underlying":"Common Shares","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001348362-25-000003","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1658613/000134836225000003/primary_doc.xml","form_type":"4"}},{"id":1305820,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":59461,"kind":"person","name":"BUNKA CHRISTOPHER","position":1,"cik":"0001103780","reported_name":"BUNKA CHRISTOPHER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Award","published_at":"2025-01-10T16:52:41.000Z","date":"2025-01-07","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The closing price on the Issuer's shares on the date of grant was $2.24."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Beneficial ownership reflects the aggregate securities held directly."}],"balance_after":373543,"source":{"system":"sec-edgar","filing":"0001348362-25-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1103780/000134836225000001/primary_doc.xml","form_type":"4"}},{"id":1344688,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":77077,"kind":"person","name":"CHRISTOPHER RICHARD","position":1,"cik":"0001271244","reported_name":"CHRISTOPHER RICHARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"common shares","published_at":"2024-12-03T14:03:28.000Z","date":"2024-12-03","kind":"purchase","planned":false,"acquired":true,"shares":27172,"price":2.4722,"value":67174.6184,"ownership":{"direct":true},"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001348362-24-000006","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1271244/000134836224000006/primary_doc.xml","form_type":"4"}},{"id":1344687,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":77077,"kind":"person","name":"CHRISTOPHER RICHARD","position":1,"cik":"0001271244","reported_name":"CHRISTOPHER RICHARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"common shares","published_at":"2024-12-03T14:03:28.000Z","date":"2024-12-02","kind":"purchase","planned":false,"acquired":true,"shares":22828,"price":2.2436,"value":51216.9008,"ownership":{"direct":true},"balance_after":22828,"source":{"system":"sec-edgar","filing":"0001348362-24-000006","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1271244/000134836224000006/primary_doc.xml","form_type":"4"}},{"id":1434605,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":88335,"kind":"person","name":"TURKEL CATHERINE C.","position":1,"cik":"0001705278","reported_name":"TURKEL CATHERINE C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"common shares","published_at":"2024-08-13T14:55:35.000Z","date":"2024-08-12","kind":"purchase","planned":false,"acquired":true,"shares":1600,"price":3.13,"value":5008.0,"ownership":{"direct":true},"balance_after":3100,"source":{"system":"sec-edgar","filing":"0001855763-24-000013","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1348362/000185576324000013/primary_doc.xml","form_type":"4"}},{"id":1444385,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":77081,"kind":"person","name":"Carle Vanessa","position":1,"cik":"0001855763","reported_name":"Carle Vanessa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary"}}],"security":"common shares","published_at":"2024-08-01T12:25:52.000Z","date":"2024-07-31","kind":"sale","planned":false,"acquired":false,"shares":2567,"price":4,"value":10268.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001855763-24-000012","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1855763/000185576324000012/primary_doc.xml","form_type":"4"}},{"id":1446138,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":88335,"kind":"person","name":"TURKEL CATHERINE C.","position":1,"cik":"0001705278","reported_name":"TURKEL CATHERINE C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2024-07-30T15:32:13.000Z","date":"2024-07-26","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":27000,"derivative":{"exercise_price":3.39,"exercise_date":"2024-07-26","expiration_date":"2029-07-26","underlying":"Common Shares","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001348362-24-000003","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1348362/000134836224000003/primary_doc.xml","form_type":"4"}},{"id":1446160,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":79671,"kind":"person","name":"REESE ALBERT L JR","position":1,"cik":"0001244736","reported_name":"REESE ALBERT L JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2024-07-30T11:39:05.000Z","date":"2024-07-26","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":32000,"derivative":{"exercise_price":3.39,"exercise_date":"2024-07-26","expiration_date":"2029-07-26","underlying":"Common Shares","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001348362-24-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1244736/000134836224000004/primary_doc.xml","form_type":"4"}},{"id":1446146,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":79670,"kind":"person","name":"Baxter Nicholas W","position":1,"cik":"0001312326","reported_name":"Baxter Nicholas W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2024-07-30T11:25:41.000Z","date":"2024-07-26","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":52000,"derivative":{"exercise_price":3.39,"exercise_date":"2024-07-26","expiration_date":"2029-07-26","underlying":"Common Shares","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001348362-24-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1312326/000134836224000002/primary_doc.xml","form_type":"4"}},{"id":1446247,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":77080,"kind":"person","name":"McKechnie William Edward","position":1,"cik":"0001658613","reported_name":"McKechnie William Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2024-07-30T11:12:28.000Z","date":"2024-07-26","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":52000,"derivative":{"exercise_price":3.39,"exercise_date":"2024-07-26","expiration_date":"2029-07-26","underlying":"Common Shares","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001348362-24-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1658613/000134836224000001/primary_doc.xml","form_type":"4"}},{"id":1516147,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":77081,"kind":"person","name":"Carle Vanessa","position":1,"cik":"0001855763","reported_name":"Carle Vanessa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary"}}],"security":"Stock Options","published_at":"2024-05-15T17:37:12.000Z","date":"2024-05-14","kind":"exercise","planned":false,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":60067,"derivative":{"exercise_price":1.15,"exercise_date":"2023-10-26","expiration_date":"2028-10-26","underlying":"Common Shares","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001855763-24-000011","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1855763/000185576324000011/primary_doc.xml","form_type":"4"}},{"id":1516146,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":77081,"kind":"person","name":"Carle Vanessa","position":1,"cik":"0001855763","reported_name":"Carle Vanessa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary"}}],"security":"common shares","published_at":"2024-05-15T17:37:12.000Z","date":"2024-05-14","kind":"exercise","planned":false,"acquired":true,"shares":2500,"price":1.15,"value":2875.0,"ownership":{"direct":true},"balance_after":2567,"source":{"system":"sec-edgar","filing":"0001855763-24-000011","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1855763/000185576324000011/primary_doc.xml","form_type":"4"}},{"id":1520425,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":88335,"kind":"person","name":"TURKEL CATHERINE C.","position":1,"cik":"0001705278","reported_name":"TURKEL CATHERINE C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2024-05-10T21:16:29.000Z","date":"2024-04-26","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":15000,"derivative":{"exercise_price":2.36,"exercise_date":"2024-04-26","expiration_date":"2029-04-26","underlying":"Common Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001855763-24-000009","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1348362/000185576324000009/primary_doc.xml","form_type":"4"}},{"id":1521122,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":59461,"kind":"person","name":"BUNKA CHRISTOPHER","position":1,"cik":"0001103780","reported_name":"BUNKA CHRISTOPHER","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2024-05-10T20:44:46.000Z","date":"2024-04-26","kind":"grant","planned":false,"acquired":true,"shares":49500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":180501,"derivative":{"exercise_price":2.36,"exercise_date":"2024-04-26","expiration_date":"2029-04-26","underlying":"Common Shares","underlying_shares":49500},"source":{"system":"sec-edgar","filing":"0001855763-24-000005","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1103780/000185576324000005/primary_doc.xml","form_type":"4"}},{"id":1520922,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":77081,"kind":"person","name":"Carle Vanessa","position":1,"cik":"0001855763","reported_name":"Carle Vanessa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary"}}],"security":"Stock Options","published_at":"2024-05-10T17:24:01.000Z","date":"2024-04-26","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":62567,"derivative":{"exercise_price":2.36,"exercise_date":"2024-04-26","expiration_date":"2029-04-26","underlying":"Common Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001855763-24-000010","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1855763/000185576324000010/primary_doc.xml","form_type":"4"}},{"id":1520428,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":79670,"kind":"person","name":"Baxter Nicholas W","position":1,"cik":"0001312326","reported_name":"Baxter Nicholas W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2024-05-10T17:11:58.000Z","date":"2024-04-26","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":40000,"derivative":{"exercise_price":2.36,"exercise_date":"2024-04-26","expiration_date":"2029-04-26","underlying":"Common Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001855763-24-000008","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1312326/000185576324000008/primary_doc.xml","form_type":"4"}},{"id":1520677,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":77080,"kind":"person","name":"McKechnie William Edward","position":1,"cik":"0001658613","reported_name":"McKechnie William Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2024-05-10T17:03:21.000Z","date":"2024-04-26","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":40000,"derivative":{"exercise_price":2.36,"exercise_date":"2024-04-26","expiration_date":"2029-04-26","underlying":"Common Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001855763-24-000007","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1658613/000185576324000007/primary_doc.xml","form_type":"4"}},{"id":1520470,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":79671,"kind":"person","name":"REESE ALBERT L JR","position":1,"cik":"0001244736","reported_name":"REESE ALBERT L JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2024-05-10T16:52:23.000Z","date":"2024-04-26","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20000,"derivative":{"exercise_price":2.36,"exercise_date":"2024-04-26","expiration_date":"2029-04-26","underlying":"Common Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001855763-24-000006","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1244736/000185576324000006/primary_doc.xml","form_type":"4"}},{"id":1520672,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":77079,"kind":"person","name":"DOCHERTY JOHN MARTIN","position":1,"cik":"0001638727","reported_name":"DOCHERTY JOHN MARTIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Options","published_at":"2024-05-10T16:34:46.000Z","date":"2024-04-26","kind":"grant","planned":false,"acquired":true,"shares":49500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":174168,"derivative":{"exercise_price":2.36,"exercise_date":"2024-04-26","expiration_date":"2029-04-26","underlying":"Common Shares","underlying_shares":49500},"source":{"system":"sec-edgar","filing":"0001855763-24-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1638727/000185576324000004/primary_doc.xml","form_type":"4"}},{"id":1752524,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":77081,"kind":"person","name":"Carle Vanessa","position":1,"cik":"0001855763","reported_name":"Carle Vanessa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary"}}],"security":"Stock Options","published_at":"2023-11-01T13:45:34.000Z","date":"2023-10-26","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":52567,"derivative":{"exercise_price":1.15,"exercise_date":"2023-10-26","expiration_date":"2028-10-26","underlying":"Common Shares","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001855763-23-000009","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1855763/000185576323000009/primary_doc.xml","form_type":"4"}},{"id":1754005,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":59461,"kind":"person","name":"BUNKA CHRISTOPHER","position":1,"cik":"0001103780","reported_name":"BUNKA CHRISTOPHER","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2023-10-30T16:30:47.000Z","date":"2023-10-26","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":131001,"derivative":{"exercise_price":1.15,"exercise_date":"2023-10-26","expiration_date":"2028-10-26","underlying":"Common Shares","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001855763-23-000007","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1103780/000185576323000007/primary_doc.xml","form_type":"4"}},{"id":1753806,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":77079,"kind":"person","name":"DOCHERTY JOHN MARTIN","position":1,"cik":"0001638727","reported_name":"DOCHERTY JOHN MARTIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Options","published_at":"2023-10-30T12:47:17.000Z","date":"2023-10-26","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":124668,"derivative":{"exercise_price":1.15,"exercise_date":"2023-10-26","expiration_date":"2028-10-26","underlying":"Common Shares","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001855763-23-000008","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1638727/000185576323000008/primary_doc.xml","form_type":"4"}},{"id":1823413,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":88335,"kind":"person","name":"TURKEL CATHERINE C.","position":1,"cik":"0001705278","reported_name":"TURKEL CATHERINE C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2023-07-25T17:44:44.000Z","date":"2023-07-25","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10000,"derivative":{"exercise_price":0.87,"exercise_date":"2023-07-25","expiration_date":"2028-07-25","underlying":"Common Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001855763-23-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1348362/000185576323000002/primary_doc.xml","form_type":"4"}},{"id":1823424,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":79670,"kind":"person","name":"Baxter Nicholas W","position":1,"cik":"0001312326","reported_name":"Baxter Nicholas W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2023-07-25T14:35:07.000Z","date":"2023-07-25","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":35000,"derivative":{"exercise_price":0.87,"exercise_date":"2023-07-25","expiration_date":"2028-07-25","underlying":"Common Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001855763-23-000005","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1312326/000185576323000005/primary_doc.xml","form_type":"4"}},{"id":1823491,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":77080,"kind":"person","name":"McKechnie William Edward","position":1,"cik":"0001658613","reported_name":"McKechnie William Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2023-07-25T14:09:26.000Z","date":"2023-07-25","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":35000,"derivative":{"exercise_price":0.87,"exercise_date":"2023-07-25","expiration_date":"2028-07-25","underlying":"Common Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001855763-23-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1658613/000185576323000004/primary_doc.xml","form_type":"4"}},{"id":1823438,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":79671,"kind":"person","name":"REESE ALBERT L JR","position":1,"cik":"0001244736","reported_name":"REESE ALBERT L JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2023-07-25T13:56:04.000Z","date":"2023-07-25","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":15000,"derivative":{"exercise_price":0.87,"exercise_date":"2023-07-25","expiration_date":"2028-07-25","underlying":"Common Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001855763-23-000003","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1244736/000185576323000003/primary_doc.xml","form_type":"4"}},{"id":1989870,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":88335,"kind":"person","name":"TURKEL CATHERINE C.","position":1,"cik":"0001705278","reported_name":"TURKEL CATHERINE C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-02-27T15:52:10.000Z","date":"2023-02-09","kind":"purchase","acquired":true,"shares":1500,"price":2.8446,"value":4266.9,"ownership":{"direct":true},"balance_after":1500,"source":{"system":"sec-edgar","filing":"0001855763-23-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1348362/000185576323000001/primary_doc.xml","form_type":"4"}},{"id":2135821,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":59461,"kind":"person","name":"BUNKA CHRISTOPHER","position":1,"cik":"0001103780","reported_name":"BUNKA CHRISTOPHER","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"common shares","published_at":"2022-10-18T22:20:31.000Z","date":"2022-10-13","kind":"purchase","acquired":true,"shares":16600,"price":2.1,"value":34860.0,"ownership":{"direct":false,"nature":"Private Holding Company"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4/A is being filed to correct the transaction code for the open market purchase of common shares made by Mr. Bunka as previously notated as a grant or award in the Form 4 originally filed on 10/13/2022."}],"balance_after":254412,"source":{"system":"sec-edgar","filing":"0001855763-22-000019","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1103780/000185576322000019/primary_doc.xml","form_type":"4/A","original_submission_date":"2022-10-13"}},{"id":2135820,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":59461,"kind":"person","name":"BUNKA CHRISTOPHER","position":1,"cik":"0001103780","reported_name":"BUNKA CHRISTOPHER","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"common shares","published_at":"2022-10-18T22:20:31.000Z","date":"2022-10-12","kind":"purchase","acquired":true,"shares":21900,"price":1.988,"value":43537.2,"ownership":{"direct":false,"nature":"Private Holding Company"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4/A is being filed to correct the transaction code for the open market purchase of common shares made by Mr. Bunka as previously notated as a grant or award in the Form 4 originally filed on 10/13/2022."}],"balance_after":237812,"source":{"system":"sec-edgar","filing":"0001855763-22-000019","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1103780/000185576322000019/primary_doc.xml","form_type":"4/A","original_submission_date":"2022-10-13"}},{"id":2135676,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":123023,"kind":"person","name":"Downey Gregory","position":1,"cik":"0001855801","reported_name":"Downey Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"common shares","published_at":"2022-10-18T18:31:43.000Z","date":"2022-10-14","kind":"purchase","acquired":true,"shares":121,"price":2.09,"value":252.89,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4A is being filed to correct the transaction code for the open market purchase made by Mr. Downey as originally notated as a grant or award in the Form 4 filed on October 18, 2022."}],"balance_after":1954,"source":{"system":"sec-edgar","filing":"0001855763-22-000020","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1855801/000185576322000020/primary_doc.xml","form_type":"4/A","original_submission_date":"2022-10-18"}},{"id":2135675,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":123023,"kind":"person","name":"Downey Gregory","position":1,"cik":"0001855801","reported_name":"Downey Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"common shares","published_at":"2022-10-18T14:34:55.000Z","date":"2022-10-14","kind":"grant","acquired":true,"shares":121,"price":2.09,"value":252.89,"ownership":{"direct":true},"balance_after":1954,"source":{"system":"sec-edgar","filing":"0001855763-22-000018","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1855801/000185576322000018/primary_doc.xml","form_type":"4"}},{"id":2137555,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":88335,"kind":"person","name":"TURKEL CATHERINE C.","position":1,"cik":"0001705278","reported_name":"TURKEL CATHERINE C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-10-13T21:16:36.000Z","date":"2022-10-12","kind":"grant","acquired":true,"shares":1600,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5000,"derivative":{"exercise_price":1.96,"exercise_date":"2022-10-12","expiration_date":"2027-10-12","underlying":"Common Shares","underlying_shares":1600},"source":{"system":"sec-edgar","filing":"0001855763-22-000015","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1348362/000185576322000015/primary_doc.xml","form_type":"4"}},{"id":2137893,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":59461,"kind":"person","name":"BUNKA CHRISTOPHER","position":1,"cik":"0001103780","reported_name":"BUNKA CHRISTOPHER","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"common shares","published_at":"2022-10-13T21:00:46.000Z","date":"2022-10-13","kind":"grant","acquired":true,"shares":16600,"price":2.1,"value":34860.0,"ownership":{"direct":false,"nature":"Private Holding Company"},"balance_after":254412,"source":{"system":"sec-edgar","filing":"0001855763-22-000014","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1103780/000185576322000014/primary_doc.xml","form_type":"4"}},{"id":2137892,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":59461,"kind":"person","name":"BUNKA CHRISTOPHER","position":1,"cik":"0001103780","reported_name":"BUNKA CHRISTOPHER","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"common shares","published_at":"2022-10-13T21:00:46.000Z","date":"2022-10-12","kind":"grant","acquired":true,"shares":21900,"price":1.988,"value":43537.2,"ownership":{"direct":false,"nature":"Private Holding Company"},"balance_after":237812,"source":{"system":"sec-edgar","filing":"0001855763-22-000014","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1103780/000185576322000014/primary_doc.xml","form_type":"4"}},{"id":2137682,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":77080,"kind":"person","name":"McKechnie William Edward","position":1,"cik":"0001658613","reported_name":"McKechnie William Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-10-13T17:31:40.000Z","date":"2022-10-12","kind":"grant","acquired":true,"shares":18200,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":30000,"derivative":{"exercise_price":1.96,"exercise_date":"2022-10-12","expiration_date":"2027-10-12","underlying":"Common Shares","underlying_shares":18200},"source":{"system":"sec-edgar","filing":"0001855763-22-000017","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1658613/000185576322000017/primary_doc.xml","form_type":"4"}},{"id":2137577,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":79671,"kind":"person","name":"REESE ALBERT L JR","position":1,"cik":"0001244736","reported_name":"REESE ALBERT L JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-10-13T17:25:18.000Z","date":"2022-10-12","kind":"grant","acquired":true,"shares":3200,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10000,"derivative":{"exercise_price":1.96,"exercise_date":"2022-10-12","expiration_date":"2027-10-12","underlying":"Common Shares","underlying_shares":3200},"source":{"system":"sec-edgar","filing":"0001855763-22-000016","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1244736/000185576322000016/primary_doc.xml","form_type":"4"}},{"id":2137557,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":79670,"kind":"person","name":"Baxter Nicholas W","position":1,"cik":"0001312326","reported_name":"Baxter Nicholas W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-10-13T12:49:40.000Z","date":"2022-10-12","kind":"grant","acquired":true,"shares":18200,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":30000,"derivative":{"exercise_price":1.96,"exercise_date":"2022-10-12","expiration_date":"2027-10-12","underlying":"Common Shares","underlying_shares":18200},"source":{"system":"sec-edgar","filing":"0001855763-22-000013","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1312326/000185576322000013/primary_doc.xml","form_type":"4"}},{"id":2165206,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":88335,"kind":"person","name":"TURKEL CATHERINE C.","position":1,"cik":"0001705278","reported_name":"TURKEL CATHERINE C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-09-06T16:53:24.000Z","date":"2022-09-02","kind":"grant","acquired":true,"shares":3400,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3400,"derivative":{"exercise_price":3.04,"exercise_date":"2022-09-02","expiration_date":"2027-09-02","underlying":"Common Shares","underlying_shares":3400},"source":{"system":"sec-edgar","filing":"0001855763-22-000012","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1348362/000185576322000012/primary_doc.xml","form_type":"4"}},{"id":2172185,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":59461,"kind":"person","name":"BUNKA CHRISTOPHER","position":1,"cik":"0001103780","reported_name":"BUNKA CHRISTOPHER","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2022-08-29T21:18:43.000Z","date":"2022-08-29","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":101001,"derivative":{"exercise_price":2.91,"exercise_date":"2022-08-29","expiration_date":"2027-08-29","underlying":"Common Shares","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001855763-22-000008","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1103780/000185576322000008/primary_doc.xml","form_type":"4"}},{"id":2172028,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":77081,"kind":"person","name":"Carle Vanessa","position":1,"cik":"0001855763","reported_name":"Carle Vanessa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary"}}],"security":"Stock Options","published_at":"2022-08-29T17:32:43.000Z","date":"2022-08-29","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":40067,"derivative":{"exercise_price":2.91,"exercise_date":"2022-08-29","expiration_date":"2027-08-29","underlying":"Common Shares","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001855763-22-000010","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1855763/000185576322000010/primary_doc.xml","form_type":"4"}},{"id":2171788,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":77079,"kind":"person","name":"DOCHERTY JOHN MARTIN","position":1,"cik":"0001638727","reported_name":"DOCHERTY JOHN MARTIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Options","published_at":"2022-08-29T17:26:10.000Z","date":"2022-08-29","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":94668,"derivative":{"exercise_price":2.91,"exercise_date":"2022-08-29","expiration_date":"2027-08-29","underlying":"Common Shares","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001855763-22-000009","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1638727/000185576322000009/primary_doc.xml","form_type":"4"}},{"id":2172101,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":123023,"kind":"person","name":"Downey Gregory","position":1,"cik":"0001855801","reported_name":"Downey Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options","published_at":"2022-08-29T17:08:47.000Z","date":"2022-08-29","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":46000,"derivative":{"exercise_price":2.91,"exercise_date":"2022-08-29","expiration_date":"2027-08-29","underlying":"Common Shares","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001855763-22-000007","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1855801/000185576322000007/primary_doc.xml","form_type":"4"}},{"id":2256498,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":79671,"kind":"person","name":"REESE ALBERT L JR","position":1,"cik":"0001244736","reported_name":"REESE ALBERT L JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"common shares","published_at":"2022-05-25T13:48:33.000Z","date":"2022-05-24","kind":"grant","acquired":true,"shares":5000,"price":1.958,"value":9790.0,"ownership":{"direct":true},"balance_after":10917,"source":{"system":"sec-edgar","filing":"0001855763-22-000006","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1244736/000185576322000006/primary_doc.xml","form_type":"4"}},{"id":2257947,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":79671,"kind":"person","name":"REESE ALBERT L JR","position":1,"cik":"0001244736","reported_name":"REESE ALBERT L JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"common shares","published_at":"2022-05-24T13:06:19.000Z","date":"2022-05-20","kind":"grant","acquired":true,"shares":1799,"price":2.007,"value":3610.593,"ownership":{"direct":true},"balance_after":5917,"source":{"system":"sec-edgar","filing":"0001855763-22-000005","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1244736/000185576322000005/primary_doc.xml","form_type":"4"}},{"id":2263412,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":79671,"kind":"person","name":"REESE ALBERT L JR","position":1,"cik":"0001244736","reported_name":"REESE ALBERT L JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"common shares","published_at":"2022-05-19T16:47:01.000Z","date":"2022-05-19","kind":"grant","acquired":true,"shares":1501,"price":2.01,"value":3017.01,"ownership":{"direct":true},"balance_after":4118,"source":{"system":"sec-edgar","filing":"0001855763-22-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1244736/000185576322000004/primary_doc.xml","form_type":"4"}},{"id":2263411,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":79671,"kind":"person","name":"REESE ALBERT L JR","position":1,"cik":"0001244736","reported_name":"REESE ALBERT L JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"common shares","published_at":"2022-05-19T16:47:01.000Z","date":"2022-05-18","kind":"grant","acquired":true,"shares":1700,"price":2.008,"value":3413.6,"ownership":{"direct":true},"balance_after":2617,"source":{"system":"sec-edgar","filing":"0001855763-22-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1244736/000185576322000004/primary_doc.xml","form_type":"4"}},{"id":2344112,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":79671,"kind":"person","name":"REESE ALBERT L JR","position":1,"cik":"0001244736","reported_name":"REESE ALBERT L JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-03-08T17:32:54.000Z","date":"2022-03-08","kind":"grant","acquired":true,"shares":3400,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6800,"derivative":{"exercise_price":3.39,"exercise_date":"2022-03-08","expiration_date":"2027-03-08","underlying":"Common Shares","underlying_shares":3400},"source":{"system":"sec-edgar","filing":"0001855763-22-000003","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1244736/000185576322000003/primary_doc.xml","form_type":"4"}},{"id":2344701,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":77080,"kind":"person","name":"McKechnie William Edward","position":1,"cik":"0001658613","reported_name":"McKechnie William Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-03-08T17:27:14.000Z","date":"2022-03-08","kind":"grant","acquired":true,"shares":3400,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":11800,"derivative":{"exercise_price":3.39,"exercise_date":"2022-03-08","expiration_date":"2027-03-08","underlying":"Common Shares","underlying_shares":3400},"source":{"system":"sec-edgar","filing":"0001855763-22-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1658613/000185576322000002/primary_doc.xml","form_type":"4"}},{"id":2343928,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":79670,"kind":"person","name":"Baxter Nicholas W","position":1,"cik":"0001312326","reported_name":"Baxter Nicholas W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-03-08T17:18:41.000Z","date":"2022-03-08","kind":"grant","acquired":true,"shares":3400,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":11800,"derivative":{"exercise_price":3.39,"exercise_date":"2022-03-08","expiration_date":"2027-03-08","underlying":"Common Shares","underlying_shares":3400},"source":{"system":"sec-edgar","filing":"0001855763-22-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1312326/000185576322000001/primary_doc.xml","form_type":"4"}},{"id":2582403,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":59461,"kind":"person","name":"BUNKA CHRISTOPHER","position":1,"cik":"0001103780","reported_name":"BUNKA CHRISTOPHER","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Options","published_at":"2021-09-02T17:58:39.000Z","date":"2021-09-01","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":71001,"derivative":{"exercise_price":6.23,"exercise_date":"2021-09-01","expiration_date":"2026-09-01","underlying":"Common Shares","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001855763-21-000027","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1103780/000185576321000027/primary_doc.xml","form_type":"4"}},{"id":2581649,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":77079,"kind":"person","name":"DOCHERTY JOHN MARTIN","position":1,"cik":"0001638727","reported_name":"DOCHERTY JOHN MARTIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Options","published_at":"2021-09-02T13:49:07.000Z","date":"2021-09-01","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":64668,"derivative":{"exercise_price":6.23,"exercise_date":"2021-09-01","expiration_date":"2026-09-01","underlying":"Common Shares","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001855763-21-000026","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1638727/000185576321000026/primary_doc.xml","form_type":"4"}},{"id":2581655,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":77080,"kind":"person","name":"McKechnie William Edward","position":1,"cik":"0001658613","reported_name":"McKechnie William Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2021-09-02T13:41:25.000Z","date":"2021-09-01","kind":"grant","acquired":true,"shares":1900,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8400,"derivative":{"exercise_price":6.23,"exercise_date":"2021-09-01","expiration_date":"2026-09-01","underlying":"Common Shares","underlying_shares":1900},"source":{"system":"sec-edgar","filing":"0001855763-21-000025","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1658613/000185576321000025/primary_doc.xml","form_type":"4"}},{"id":2581264,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":79670,"kind":"person","name":"Baxter Nicholas W","position":1,"cik":"0001312326","reported_name":"Baxter Nicholas W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2021-09-02T13:32:02.000Z","date":"2021-09-01","kind":"grant","acquired":true,"shares":1900,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8400,"derivative":{"exercise_price":6.23,"exercise_date":"2021-09-01","expiration_date":"2026-09-01","underlying":"Common Shares","underlying_shares":1900},"source":{"system":"sec-edgar","filing":"0001855763-21-000024","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1312326/000185576321000024/primary_doc.xml","form_type":"4"}},{"id":2581959,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":123023,"kind":"person","name":"Downey Gregory","position":1,"cik":"0001855801","reported_name":"Downey Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options","published_at":"2021-09-02T13:19:16.000Z","date":"2021-09-01","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":35000,"derivative":{"exercise_price":6.23,"exercise_date":"2021-09-01","expiration_date":"2026-09-01","underlying":"Common Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001855763-21-000023","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1855801/000185576321000023/primary_doc.xml","form_type":"4"}},{"id":2581957,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":77081,"kind":"person","name":"Carle Vanessa","position":1,"cik":"0001855763","reported_name":"Carle Vanessa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary"}}],"security":"Stock Options","published_at":"2021-09-02T13:04:43.000Z","date":"2021-09-01","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":27567,"derivative":{"exercise_price":6.23,"exercise_date":"2021-09-01","expiration_date":"2026-09-01","underlying":"Common Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001855763-21-000022","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1855763/000185576321000022/primary_doc.xml","form_type":"4"}},{"id":2628029,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":79671,"kind":"person","name":"REESE ALBERT L JR","position":1,"cik":"0001244736","reported_name":"REESE ALBERT L JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2021-07-21T13:32:25.000Z","date":"2021-02-01","kind":"grant","acquired":true,"shares":3400,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3400,"derivative":{"exercise_price":4.8,"exercise_date":"2021-02-01","expiration_date":"2026-02-01","underlying":"Common Shares","underlying_shares":3400},"source":{"system":"sec-edgar","filing":"0001855763-21-000021","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1244736/000185576321000021/primary_doc.xml","form_type":"4"}},{"id":2676362,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":59461,"kind":"person","name":"BUNKA CHRISTOPHER","position":1,"cik":"0001103780","reported_name":"BUNKA CHRISTOPHER","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Options","published_at":"2021-06-09T16:57:04.000Z","date":"2021-06-08","kind":"grant","acquired":true,"shares":23334,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":56001,"derivative":{"exercise_price":7.08,"exercise_date":"2021-06-08","expiration_date":"2026-06-08","underlying":"Common Shares","underlying_shares":23334},"source":{"system":"sec-edgar","filing":"0001855763-21-000016","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1103780/000185576321000016/primary_doc.xml","form_type":"4"}},{"id":2676361,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":59461,"kind":"person","name":"BUNKA CHRISTOPHER","position":1,"cik":"0001103780","reported_name":"BUNKA CHRISTOPHER","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Options","published_at":"2021-06-09T16:48:45.000Z","date":"2021-05-07","kind":"other","acquired":false,"shares":23334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Cancelled Options"}],"balance_after":32667,"derivative":{"exercise_price":10.2,"exercise_date":"2020-04-23","expiration_date":"2025-04-23","underlying":"Common Shares","underlying_shares":23334},"source":{"system":"sec-edgar","filing":"0001855763-21-000015","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1103780/000185576321000015/primary_doc.xml","form_type":"4"}},{"id":2675631,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":77079,"kind":"person","name":"DOCHERTY JOHN MARTIN","position":1,"cik":"0001638727","reported_name":"DOCHERTY JOHN MARTIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Options","published_at":"2021-06-09T13:40:37.000Z","date":"2021-06-08","kind":"grant","acquired":true,"shares":18334,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":49668,"derivative":{"exercise_price":7.08,"exercise_date":"2021-06-08","expiration_date":"2026-06-08","underlying":"Common Shares","underlying_shares":18334},"source":{"system":"sec-edgar","filing":"0001855763-21-000020","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1638727/000185576321000020/primary_doc.xml","form_type":"4"}},{"id":2675630,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":77079,"kind":"person","name":"DOCHERTY JOHN MARTIN","position":1,"cik":"0001638727","reported_name":"DOCHERTY JOHN MARTIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Options","published_at":"2021-06-09T13:34:01.000Z","date":"2021-05-07","kind":"other","acquired":false,"shares":18334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Cancellation of Options"}],"balance_after":31334,"derivative":{"exercise_price":14.1,"exercise_date":"2020-02-07","expiration_date":"2025-02-07","underlying":"Common Shares","underlying_shares":18334},"source":{"system":"sec-edgar","filing":"0001855763-21-000019","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1638727/000185576321000019/primary_doc.xml","form_type":"4"}},{"id":2675662,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":77080,"kind":"person","name":"McKechnie William Edward","position":1,"cik":"0001658613","reported_name":"McKechnie William Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2021-06-09T13:14:46.000Z","date":"2021-06-08","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6500,"derivative":{"exercise_price":7.08,"exercise_date":"2021-06-08","expiration_date":"2026-06-08","underlying":"Common Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001855763-21-000018","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1658613/000185576321000018/primary_doc.xml","form_type":"4"}},{"id":2675661,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":77080,"kind":"person","name":"McKechnie William Edward","position":1,"cik":"0001658613","reported_name":"McKechnie William Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2021-06-09T13:05:42.000Z","date":"2021-05-07","kind":"other","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Cancelled Options"}],"balance_after":1500,"derivative":{"exercise_price":9.6,"exercise_date":"2020-04-23","expiration_date":"2025-04-23","underlying":"Common Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001855763-21-000017","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1658613/000185576321000017/primary_doc.xml","form_type":"4"}},{"id":2676009,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":123023,"kind":"person","name":"Downey Gregory","position":1,"cik":"0001855801","reported_name":"Downey Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options","published_at":"2021-06-09T12:38:11.000Z","date":"2021-06-08","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25000,"derivative":{"exercise_price":7.08,"exercise_date":"2021-06-08","expiration_date":"2026-06-08","underlying":"Common Shares","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001855763-21-000014","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1855801/000185576321000014/primary_doc.xml","form_type":"4"}},{"id":2676008,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":123023,"kind":"person","name":"Downey Gregory","position":1,"cik":"0001855801","reported_name":"Downey Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options","published_at":"2021-06-09T12:32:08.000Z","date":"2021-05-07","kind":"other","acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Cancelled Options"}],"balance_after":17000,"derivative":{"exercise_price":9.6,"exercise_date":"2020-04-23","expiration_date":"2025-04-23","underlying":"Common Shares","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001855763-21-000013","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1855801/000185576321000013/primary_doc.xml","form_type":"4"}},{"id":2675281,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":79670,"kind":"person","name":"Baxter Nicholas W","position":1,"cik":"0001312326","reported_name":"Baxter Nicholas W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2021-06-09T11:32:59.000Z","date":"2021-06-08","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6500,"derivative":{"exercise_price":7.08,"exercise_date":"2021-06-08","expiration_date":"2026-06-08","underlying":"Common Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001855763-21-000012","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1312326/000185576321000012/primary_doc.xml","form_type":"4"}},{"id":2675280,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":79670,"kind":"person","name":"Baxter Nicholas W","position":1,"cik":"0001312326","reported_name":"Baxter Nicholas W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2021-06-09T11:23:14.000Z","date":"2021-05-07","kind":"other","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Cancellation of Options"}],"balance_after":1500,"derivative":{"exercise_price":9.6,"exercise_date":"2020-04-23","expiration_date":"2025-04-23","underlying":"Common Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001855763-21-000011","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1312326/000185576321000011/primary_doc.xml","form_type":"4"}},{"id":2676007,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":77081,"kind":"person","name":"Carle Vanessa","position":1,"cik":"0001855763","reported_name":"Carle Vanessa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary"}}],"security":"Stock Options","published_at":"2021-06-09T11:15:13.000Z","date":"2021-06-08","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":17567,"derivative":{"exercise_price":7.08,"exercise_date":"2021-06-08","expiration_date":"2026-06-08","underlying":"Common Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001855763-21-000010","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1855763/000185576321000010/primary_doc.xml","form_type":"4"}},{"id":2676006,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":77081,"kind":"person","name":"Carle Vanessa","position":1,"cik":"0001855763","reported_name":"Carle Vanessa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary"}}],"security":"Stock Options","published_at":"2021-06-09T11:07:14.000Z","date":"2021-05-07","kind":"other","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Cancellation of Options"}],"balance_after":12567,"derivative":{"exercise_price":9.6,"exercise_date":"2020-04-23","expiration_date":"2025-04-23","underlying":"Common Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001855763-21-000009","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1855763/000185576321000009/primary_doc.xml","form_type":"4"}},{"id":2738858,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":59461,"kind":"person","name":"BUNKA CHRISTOPHER","position":1,"cik":"0001103780","reported_name":"BUNKA CHRISTOPHER","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Stock Options","published_at":"2021-04-27T21:13:00.000Z","date":"2021-04-26","kind":"grant","acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":56001,"derivative":{"exercise_price":5.83,"exercise_date":"2021-04-26","expiration_date":"2026-04-26","underlying":"Common Shares","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001855763-21-000006","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1103780/000185576321000006/primary_doc.xml","form_type":"4"}},{"id":2738479,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":77080,"kind":"person","name":"McKechnie William Edward","position":1,"cik":"0001658613","reported_name":"McKechnie William Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2021-04-27T18:11:19.000Z","date":"2021-04-26","kind":"grant","acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6500,"derivative":{"exercise_price":5.31,"exercise_date":"2021-04-26","expiration_date":"2026-04-26","underlying":"Common Shares","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001855763-21-000008","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1658613/000185576321000008/primary_doc.xml","form_type":"4"}},{"id":2738687,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":123023,"kind":"person","name":"Downey Gregory","position":1,"cik":"0001855801","reported_name":"Downey Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options","published_at":"2021-04-27T17:21:35.000Z","date":"2021-04-26","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25000,"derivative":{"exercise_price":5.31,"exercise_date":"2022-04-26","expiration_date":"2026-04-26","underlying":"Common Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001855763-21-000007","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1855801/000185576321000007/primary_doc.xml","form_type":"4"}},{"id":2738477,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":77079,"kind":"person","name":"DOCHERTY JOHN MARTIN","position":1,"cik":"0001638727","reported_name":"DOCHERTY JOHN MARTIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Options","published_at":"2021-04-27T16:58:49.000Z","date":"2021-04-26","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":49668,"derivative":{"exercise_price":5.31,"exercise_date":"2021-04-26","expiration_date":"2026-04-26","underlying":"Common Shares","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001855763-21-000005","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1638727/000185576321000005/primary_doc.xml","form_type":"4"}},{"id":2738270,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":79670,"kind":"person","name":"Baxter Nicholas W","position":1,"cik":"0001312326","reported_name":"Baxter Nicholas W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2021-04-27T16:52:16.000Z","date":"2021-04-26","kind":"grant","acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6500,"derivative":{"exercise_price":5.31,"exercise_date":"2021-04-26","expiration_date":"2026-04-26","underlying":"Common Shares","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001855763-21-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1312326/000185576321000004/primary_doc.xml","form_type":"4"}},{"id":2738685,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":77081,"kind":"person","name":"Carle Vanessa","position":1,"cik":"0001855763","reported_name":"Carle Vanessa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary"}}],"security":"Stock Options","published_at":"2021-04-27T16:31:47.000Z","date":"2021-04-26","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":17567,"derivative":{"exercise_price":5.31,"exercise_date":"2021-04-26","expiration_date":"2026-04-26","underlying":"Common Shares","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001855763-21-000003","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1855763/000185576321000003/primary_doc.xml","form_type":"4"}},{"id":2987008,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":59461,"kind":"person","name":"BUNKA CHRISTOPHER","position":1,"cik":"0001103780","reported_name":"BUNKA CHRISTOPHER","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"common shares","published_at":"2020-11-10T20:48:19.000Z","date":"2020-11-10","kind":"purchase","acquired":true,"shares":25500,"price":0.1882,"value":4799.1,"ownership":{"direct":false,"nature":"Private Holding Company"},"balance_after":6477344,"source":{"system":"sec-edgar","filing":"0001103780-20-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1103780/000110378020000004/primary_doc.xml","form_type":"4"}},{"id":2987007,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":59461,"kind":"person","name":"BUNKA CHRISTOPHER","position":1,"cik":"0001103780","reported_name":"BUNKA CHRISTOPHER","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"common shares","published_at":"2020-11-10T20:48:19.000Z","date":"2020-11-10","kind":"purchase","acquired":true,"shares":6000,"price":0.1999,"value":1199.4,"ownership":{"direct":false,"nature":"Private Holding Company"},"balance_after":6451844,"source":{"system":"sec-edgar","filing":"0001103780-20-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1103780/000110378020000004/primary_doc.xml","form_type":"4"}},{"id":2987006,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":59461,"kind":"person","name":"BUNKA CHRISTOPHER","position":1,"cik":"0001103780","reported_name":"BUNKA CHRISTOPHER","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"common shares","published_at":"2020-11-10T20:48:19.000Z","date":"2020-11-10","kind":"purchase","acquired":true,"shares":10000,"price":0.195,"value":1950.0,"ownership":{"direct":false,"nature":"Private Holding Company"},"balance_after":6445844,"source":{"system":"sec-edgar","filing":"0001103780-20-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1103780/000110378020000004/primary_doc.xml","form_type":"4"}},{"id":2987005,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":59461,"kind":"person","name":"BUNKA CHRISTOPHER","position":1,"cik":"0001103780","reported_name":"BUNKA CHRISTOPHER","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"common shares","published_at":"2020-11-10T20:48:19.000Z","date":"2020-11-09","kind":"purchase","acquired":true,"shares":22000,"price":0.1996,"value":4391.2,"ownership":{"direct":false,"nature":"Private Holding Company"},"balance_after":6435844,"source":{"system":"sec-edgar","filing":"0001103780-20-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1103780/000110378020000004/primary_doc.xml","form_type":"4"}},{"id":2987004,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":59461,"kind":"person","name":"BUNKA CHRISTOPHER","position":1,"cik":"0001103780","reported_name":"BUNKA CHRISTOPHER","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"common shares","published_at":"2020-11-10T20:48:19.000Z","date":"2020-11-09","kind":"purchase","acquired":true,"shares":6500,"price":0.201,"value":1306.5,"ownership":{"direct":false,"nature":"Private Holding Company"},"balance_after":6413844,"source":{"system":"sec-edgar","filing":"0001103780-20-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1103780/000110378020000004/primary_doc.xml","form_type":"4"}},{"id":2987003,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":59461,"kind":"person","name":"BUNKA CHRISTOPHER","position":1,"cik":"0001103780","reported_name":"BUNKA CHRISTOPHER","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"common shares","published_at":"2020-11-10T20:48:19.000Z","date":"2020-11-09","kind":"purchase","acquired":true,"shares":8000,"price":0.2,"value":1600.0,"ownership":{"direct":false,"nature":"Private Holding Company"},"balance_after":6407344,"source":{"system":"sec-edgar","filing":"0001103780-20-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1103780/000110378020000004/primary_doc.xml","form_type":"4"}},{"id":2987002,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":59461,"kind":"person","name":"BUNKA CHRISTOPHER","position":1,"cik":"0001103780","reported_name":"BUNKA CHRISTOPHER","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"common shares","published_at":"2020-11-10T20:48:19.000Z","date":"2020-11-09","kind":"purchase","acquired":true,"shares":10000,"price":0.2129,"value":2129.0,"ownership":{"direct":false,"nature":"Private Holding Company"},"balance_after":6399344,"source":{"system":"sec-edgar","filing":"0001103780-20-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1103780/000110378020000004/primary_doc.xml","form_type":"4"}},{"id":2987001,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":59461,"kind":"person","name":"BUNKA CHRISTOPHER","position":1,"cik":"0001103780","reported_name":"BUNKA CHRISTOPHER","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"common shares","published_at":"2020-11-10T20:48:19.000Z","date":"2020-11-09","kind":"purchase","acquired":true,"shares":10000,"price":0.2025,"value":2025.0,"ownership":{"direct":false,"nature":"Private Holding Company"},"balance_after":6389344,"source":{"system":"sec-edgar","filing":"0001103780-20-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1103780/000110378020000004/primary_doc.xml","form_type":"4"}},{"id":2987000,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":59461,"kind":"person","name":"BUNKA CHRISTOPHER","position":1,"cik":"0001103780","reported_name":"BUNKA CHRISTOPHER","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"common shares","published_at":"2020-11-10T20:48:19.000Z","date":"2020-11-09","kind":"purchase","acquired":true,"shares":37500,"price":0.215,"value":8062.5,"ownership":{"direct":false,"nature":"Private Holding Company"},"balance_after":6379344,"source":{"system":"sec-edgar","filing":"0001103780-20-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1103780/000110378020000004/primary_doc.xml","form_type":"4"}},{"id":2986999,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":59461,"kind":"person","name":"BUNKA CHRISTOPHER","position":1,"cik":"0001103780","reported_name":"BUNKA CHRISTOPHER","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"common shares","published_at":"2020-11-10T20:48:19.000Z","date":"2020-11-06","kind":"purchase","acquired":true,"shares":60000,"price":0.2051,"value":12306.0,"ownership":{"direct":false,"nature":"Private Holding Company"},"balance_after":6341844,"source":{"system":"sec-edgar","filing":"0001103780-20-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1103780/000110378020000004/primary_doc.xml","form_type":"4"}},{"id":3074017,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":77080,"kind":"person","name":"McKechnie William Edward","position":1,"cik":"0001658613","reported_name":"McKechnie William Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2020-07-29T18:48:04.000Z","date":"2020-07-23","kind":"exercise","acquired":false,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":150000,"derivative":{"exercise_price":0.173,"exercise_date":"2015-09-16","expiration_date":"2020-09-16","underlying":"Common Shares","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001658613-20-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1658613/000165861320000002/primary_doc.xml","form_type":"4"}}],"next_cursor":"2020-07-29T18:48:04.000000Z,3074017"}